The company named Chad Spooner CFO of MiniMed ahead of plans to spin out the diabetes unit into a separate public firm.

Medtronic plc (NYSE: MDT), a global leader in healthcare technology, today announced the appointment of Chad Spooner ...

Medtronic plc (NYSE: MDT ), a global leader in healthcare technology, today announced the appointment of Chad Spooner as chief financial officer (CFO) of MiniMed, in advance of its intended separation ...

Medtronic has landed on a new brand for the planned spinout of its diabetes division, and it didn’t have to look very far. The new company will share a name with its flagship insulin pump, MiniMed.

The tennis pro is teaming up with the medical device giant to launch a global campaign aimed at inspiring people living with ...

Multiple headwinds contributed to this underperformance, including FDA regulatory setbacks, such as the 2021 warning letter and delayed approval of the MiniMed 780G insulin pump and Guardian 4 ...

Medtronic, Beta Bionics and Tandem Diabetes Care showcased planned patch pumps at the conference, while Senseonics shared ...

Medtronic discontinued the technology in the 2000s, but there are up to 400-500 individuals still using it as of 2022. Location Currently not on view Credit Line Gift of Medtronic Diabetes product ...

Following approval, Medtronic began a Customer Training Phase in March to test the device's real-world use. Those that used the MiniMed 670G remained in a healthy blood glucose range 74% of the time.

BTIG analysts said today that MiniMed, the Medtronic diabetes business, has some significant pipeline updates.

Insulin Pump Risks and Benefits A Clinical Appraisal of Pump Safety Standards, Adverse Event Reporting, and Research Needs. A Joint Statement of the European Association for the Study of Diabetes ...

Furthermore, the speed with which a given insulin bolus (e.g., 10 units) is applied once it has begun differs considerably between insulin pumps; our knowledge about the impact of such differences ...